瘤免疫疗法的双杆菌调制及其机制
Bo Pei1,2, Shixuan Peng3, Chuying Huang2,4,5
1Hubei Key Laboratory of Tumor Biological Behaviors, Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Wuhan, China.
Cancer immunology, immunotherapy : CII
|April 2, 2024
概括
双杆菌通过调节免疫系统来增强癌症免疫疗法的承诺. 需要进一步研究,以了解这些益生菌如何改善接受免疫检查点抑制剂 (ICI) 的患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 瘤免疫疗法,特别是免疫检查点抑制剂 (ICI),已经改变了癌症治疗,但面临着患者反应和耐药性的挑战.
- 虽然Bifidobacteria以抗瘤和免疫调节作用而闻名,但它们对癌症免疫疗法的具体影响和机制在临床环境中仍未得到充分研究.
研究的目的:
- 审查Bifidobacteria在恶性瘤中的免疫调节作用.
- 探索Bifidobacteria可能调节癌症免疫疗法的潜在机制.
- 为未来的研究和Bifidobacteria在癌症治疗中的临床应用提供基础.
主要方法:
- 文献综述专注于研究Bifidobacteria,癌症免疫疗法和免疫调节的研究.
- 对Bifidobacteria对瘤微环境和系统免疫的影响现有研究的分析.
- 与免疫检查点抑制剂 (ICI) 相结合的Bifidobacteria数据的综合.
主要成果:
- 有证据表明,Bifidobacteria具有抗瘤特性,可以调节与癌症相关的免疫反应.
- 有限的临床数据存在Bifidobacteria对ICI疗效和耐药性的直接影响.
- 建议的机制包括改变肠道微生物群,增强T细胞活性,减少免疫抑制细胞.
结论:
- 双杆菌是一种潜在的辅助疗法,可以增强癌症免疫治疗的有效性.
- 进一步的临床研究至关重要,以阐明精确的机制,并优化Bifidobacteria与ICI结合使用.
- 了解这些相互作用可能会为更广泛的癌症患者改善治疗策略.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
相关概念视频
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K